Superoxide Dismutase 2 is dispensable for platelet function.

Area of Science:

• Biochemistry
• Hematology
• Mitochondrial Biology

Background:

• Increased intracellular reactive oxygen species (ROS) are linked to platelet activation.
• The role of mitochondrial ROS in platelet function remains unclear, though studies in sickle cell disease and diabetes suggest a correlation with dysfunction.

Purpose of the Study:

• To investigate if increased mitochondrial ROS, specifically due to the absence of superoxide dismutase 2 (SOD2), affects platelet activation and function.
• To determine the impact of SOD2 deficiency in platelets on thrombosis and inflammatory disease models.

Main Methods:

• Generated platelet-specific superoxide dismutase 2 knockout (SOD2-KO) mice.
• Assessed platelet ROS levels, mitochondrial function, and activation in vitro.
• Evaluated tail-bleeding time, arterial thrombosis, and outcomes in sepsis and autoimmune arthritis models in vivo.

Main Results:

• SOD2-KO platelets exhibited reduced SOD2 activity and elevated mitochondrial ROS, but total cellular ROS remained unchanged.
• Non-stimulated platelet mitochondrial function was preserved, but thrombin stimulation led to decreased mitochondrial function in SOD2-KO platelets.
• In vitro platelet activation, spreading, and in vivo thrombosis and bleeding parameters were not altered by SOD2 deletion.
• SOD2-KO mice showed no phenotypic differences compared to wildtype controls in models of sepsis and autoimmune inflammatory arthritis.

Conclusions:

• Increased mitochondrial ROS, even when elevated due to SOD2 deficiency, does not lead to platelet dysfunction.
• Platelet function and response in thrombosis and inflammatory conditions are not critically dependent on mitochondrial ROS levels regulated by SOD2.